Skip to main content
Download PDF

Utilization of public health care by people with private health insurance: a systematic review and meta-analysis

BMC Public Health volume 20, Article number: 1153 (2020) Cite this article

Abstract

Background

The objective of this systematic review was to explore the association between private health insurance and health care utilization.

Methods

We searched the MEDLINE, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRAL) electronic databases for relevant articles since 2010. Studies were eligible if they described original empirical research on the utilization of public health care by individuals with private health insurance, compared with individuals without private insurance. A pooled measure of association between insurance status with health care utilization was assessed through meta-analysis.

Results

Twenty-six articles were included in the final analysis. We found that patients with private insurance did not use more public health care than people without private insurance (P < 0.05). According to the subgroup analysis, people with private insurance were more likely to be hospitalized than people with no insurance (OR 1.67; 95% CI, 1.18 to 2.36).

Conclusions

People with private insurance did not increase their use of health care (outpatient services), compared to those without private insurance. Private health insurance coverage may ease the financial burden on patients and on the public health insurance system.

Peer Review reports

Background

As most countries across the world face rapidly escalating health expenditures, exorbitant out-of-pocket payments have resulted in high demand for supplementary private health insurance [1, 2]. For instance, in 2015, approximately 80% of households in the United States had to purchase at least one private health insurance plan, and more than 25% of Brazilians had private health insurance in 2019 [3, 4].

The role of private health insurance is fiercely debated. Some researchers believe that the use of private health insurance should be encouraged in order to ease the financial burden on patients and on social healthcare systems [5]. However, others maintain that the use of private health insurance will contribute to the current rapid increase in health expenditures, induce fragmentation of the healthcare system, and aggravate social inequity by increasing the gap in health care utilization between opposite ends of the socioeconomic spectrum [6, 7]. One of the critical controversies over private health insurance is its potential impact on health care utilization. If individuals with private health insurance increase their utilization of health care, the result will be inequity in health care utilization between those who purchase private health insurance and those who do not.

Although previous studies have examined the effect of private insurance on the utilization of public health care in specific countries [3, 6], no study published to date has systematically investigated the issue on a global scale. However, it is necessary for stakeholders to understand the role that private insurance companies play the use of healthcare services from a macro perspective. The objective of this systematic review was to synthesize available evidence to compare the effect of private health insurance to the effect of having no (private) insurance or public health care insurance on the utilization of health care (inpatient and outpatient resources) among all kinds of patients worldwide.

Methods

Search strategy

This systematic review was performed in accordance with the recommendations of the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines, but the review protocol was not registered [8]. Two reviewers searched MEDLINE, EMBASE, and the Cochrane Central Register of Controlled Trials (CENTRAL) databases for relevant articles published from January 1, 2010 to June 1, 2019. The search terms used included: “health insurance,” “private or commercial health plan(s),” “private or commercial health insurance,” “private or commercial health company,” “health within six words around the word of utilization or utility,” and “hospital within six words around the word of utilization or utility” (see detailed search strategies in Additional file 1). We searched for additional references by cross-checking the reference lists of the studies retrieved and of relevant reviews. We also contacted researchers in the field to identify trials that were eligible for inclusion.

Inclusion and exclusion criteria

We included both prospective and retrospective longitudinal controlled studies in this systematic review. Studies were eligible if they described original empirical research on the utilization of health care by individuals with private health insurance. The eligibility criteria were: 1) original studies (randomized controlled trial, case-control, cohort, cross-sectional, or pre-post); 2) one group of study participants with private health insurance (exposure group); 3) one group of study participants without private insurance (control); 4) utilization of health care [outpatient services: emergency department (ED) visits, clinic visits; inpatient services: length of stay (LOS), hospitalization rate] as an outcome [9]; 5) publication in the English language in 2010 or later. Reviews, commentaries, protocols, editorials, case reports, qualitative research, and letters were excluded. Studies on diagnostic support (e.g., radiology, clinical pathology) were also excluded. If two articles were found to derive from the same study, only the original study was included. However, if different target outcomes were reported, then both papers were included.

Study selection

Titles and abstracts were first screened for relevance by two independent reviewers, and full-text articles with potential eligibility were downloaded for further assessment. When consensus could not be reached, disagreements were resolved by consulting a third author.

Data collection

Data were collected with an extraction form validated in pilot studies. The data items extracted in this review were as follows: (1) The surname of the first author with the year in which the paper was published; (2) study design; (3) country in which the study was conducted; (4) full report or abstract; (5) target population; (6) target exposure group; (7) target control group; (8) target outcomes [emergency department (ED) visits, clinic visits, length of stay (LOS), and/or hospitalization rate]; (9) the numerical data included the number of visits to the ED, the percentages of visits to the ED, the rates of hospitalization, the rates of outpatient office visits, and the length of inpatient stays (days).

Quality assessment

Risk of bias was assessed independently by two reviewers. We applied the ROBINS I tool to assess the risk of bias among non-randomized intervention studies [10]. Risk of bias was assessed at the study level, and these results were used to inform a GRADE evidence assessment [11].

Statistical analysis

We performed meta-analyses of the studies to obtain a pooled estimate for the utilization of health care by individuals with private health insurance, compared with individuals without private health insurance. Odds ratios [with 95% confidence intervals (CIs)] were obtained for the rates of visits to the ED, the percentages of ED visits, and the rates of hospitalization with Review Manager 5.3 software [12]. Using the same software program, mean differences were obtained for the rates of outpatient office visits and the length of inpatient stay (days). P-values < 0.05 were considered as statistically significant. Between-study heterogeneity was measured using Cochrane’s Q-test and the Higgins I2 statistic (P < 0.10 or I2 > 50%) was considered as statistically significant heterogeneity [13]. When heterogeneity was present, a random-effect model (Der Simonian and Laird method) was applied. The fixed-effect model was used in the absence of between-study heterogeneity (P > 0.10 or I2 < 50%). As sensitivity analysis to confirm the robustness of our results, we performed a subgroup analysis for the control arm of no private health insurance in order to distinguish individuals with no insurance from individuals with public insurance.

Results

Study selection

A total of 8727 articles were selected by searching the selected electronic databases, and an additional five records were identified by cross-checking the reference lists of retrieved studies or relevant reviews. After excluding duplicates and screening titles and abstracts, we obtained 181 articles for full-text review. We eliminated 155 papers from among the 181 originally identified, based on our inclusion and exclusion criteria. Ultimately, 26 articles were included in the analysis (Fig. 1).

Fig. 1
figure 1

PRISMA flow diagram detailing the search strategy and results

Full size image

Study characteristics

The basic characteristics and target outcomes of included studies are listed in Table 1. All included articles (n = 26) were observational studies, in the form of abstract (n = 6) or full report (n = 20). The studies included in the meta-analysis had been conducted in the United States (57.7%, 15/26), Brazil (11.5%, 3/26), South Korea (7.7%, 2/26), Australia (7.7%, 2/26), India (7.7%, 2/26), Japan (3.8%, 1/26), and Germany (3.8%, 1/26). The study populations ranged from healthy controls to patients with specific diseases or medical conditions. Among the 26 studies included, 13 (50%) focusing on the comparison between private insurance and both no insurance and public insurance, 8 (30.8%) on the comparison between private insurance and no public insurance, and 5 studies (19.2%) compared private insurance with a lack of insurance.

Table 1 Characteristics of the included articles
Full size table

Risk of bias

We evaluated risk of bias for all full reports included in the meta-analysis (n = 20) with the ROBINS I tool. We did not assess the risk of bias in abstracts because there was insufficient information for the evaluation of methodological quality. Figure 2a shows the risk of bias for each cohort. Evaluations for each domain are shown in Fig. 2b. These figures did not include studies reported as abstracts only.

Fig. 2
figure 2

Risk of bias assessment. a Risk of bias graph: review authors’ judgements about each risk of bias item presented as percentages across all included full reported studies (n = 20). b Risk of bias summary: review authors’ judgements about each risk of bias item for each included full reported study

Full size image

Utilization of outpatient services

All detailed data extraction results can be found in Additional file 1.

ED visits

We used the data from 5 studies, which collectively included > 500,000,000 participants, to determine the odds ratio (OR) for a comparison of the rates of ED visits among people with private insurance, compared to people without private insurance [15, 19, 20, 25, 34]. The pooled results yielded an OR of 1.01 (95% CI 0.58–1.76) (Fig. 3a). There was no significant difference between people with private insurance and people without private insurance in the rate of ED visits. The results of subgroup analysis showed that this OR was similar for people with public insurance and people with no insurance (Fig. 4a).

Fig. 3
figure 3

Forest plots of the total pooling results. a for comparison of the rates of emergency department visits between private insurance and no private insurance. b for comparison of the percentages of emergency department visits between those with private insurance and those without private insurance. c for comparison of the rates of outpatient office visits between private insurance and no private insurance. d for comparison of the rates of outpatient office visits between private insurance and no private insurance. e for comparison of the length of inpatient stay (days) between those with private insurance and those without private insurance

Full size image
Fig. 4
figure 4

Forest plots of subgroup analysis according to the control of public insurance and no health insurance. a for comparison of the rates of emergency department visits between private insurance and no private insurance. b for comparison of the percentages of emergency department visits between those with private insurance and those without private insurance. c for comparison of the rates of outpatient office visits between private insurance and no private insurance. d Comparison of the length of inpatient stay (days) between those with private insurance and those without private insurance. e Comparison of the rates of hospitalization between individuals with private insurance and those with no private insurance

Full size image

Three included studies, which included 285,570 participants, reported the percentage of study participants who had visited the ED [24, 26, 32]. The proportion of those with private insurance who visited the ED was similar to the proportion of people without private insurance who visited the ED. The OR for pooled results was 0.65 (95% CI 0.27–1.60). See Fig. 3b.

The results of subgroup analysis (Fig. 4b) showed that there was no significant difference between the percentage of people with private insurance who visited the ED and either those with public insurance or those with no insurance at all.

Rate of outpatient office visits

We used the data from 7 studies, which included 120,887 participants, to determine the mean difference in the rate of outpatient office visits between people with private insurance and people without private insurance. After pooling the results, the mean difference was − 0.19 (95% CI − 0.29 to − 0.09) (see forest plot in Fig. 3c). People with private insurance were significantly less likely to visit the hospital as outpatients than people without private insurance. According to the subgroup analysis, people with private insurance were less likely to visit the outpatient office, compared to people with public insurance, and also compared to people without insurance (P < 0.05) (see forest plot in Fig. 4c). In Additional file 1, we present the data pertaining to outpatient visits that could not be included in the meta-analysis (9 articles) [15,16,17,18, 21, 25, 32, 37, 38]. The favorable results (more outpatient visits) for both people with private insurance and people without private insurance were reported.

Utilization of inpatient services

Inpatient LOS

We used the data from 4 studies, which included 304,431 participants, to determine the mean difference in LOS (days) between people with private insurance and people without private insurance [27,28,29, 33]. The mean difference in pooled results was 2.01 (95% CI − 0.15 to 4.17, Fig. 3d). There was no significant difference between people with private insurance and people without private insurance in terms of inpatient LOS.

According to the subgroup analysis (Fig. 4d), compared to people with public insurance, people with private insurance were more likely to stay longer in the hospital (mean difference (days) = 2.82, 95% CI 0.38–5.27). While there was only one study left for compared to people without private insurance with the results of mean difference of LOS (− 1.30, 95% CI − 2.15 to − 0.45), which means the favorite result (longer of LOS) for people without private insurance.

In Additional file 1, we list the data for the mean difference in LOS from 6 articles that could not be included in the meta-analysis [14, 16, 19, 25, 35, 36]. Favorable results (longer LOS) for both people with private insurance and people without private insurance were reported.

Rate of hospitalization

We used the data from 7 studies, which included > 500,000,000 participants in determining the OR for the rate of hospitalization among those with private insurance, compared with those without private insurance [15, 20, 25, 29, 32, 34, 38]. The OR for the pooled results was 1.00 (95% CI 0.58–1.70) (see forest plot in Fig. 3e). There was no significant difference in the rate of hospitalization between people with private insurance and people without private insurance.

According to the subgroup analysis (Fig. 4e), those with public insurance and those with private insurance had similar rates of hospitalization (OR = 0.72, 95% CI 0.33–1.60). Compared to people with no insurance, people with private insurance were more likely to be hospitalized (OR 1.67; 95% CI, 1.18–2.36).

The certainty of the evidence (GRADE)

The certainty of the evidence ranged from low to moderate. The observational study design meant the GRADE rating started as moderate certainty (Table 2), and almost all studies (except Abougergi et al. 2019) were missing data. Furthermore, we considered it likely that possible biases and confounding factors would have had a significant impact on the results presented in abstract form only.

Table 2 GRADE evidence profile: Healthcare service utilization for people with private insurance and without private insurance
Full size table

Discussion

In this systematic review, we investigated whether people with private insurance were more likely to utilize health care than those without private insurance. According to the results of the meta-analysis, the utilization was similar between those with and those without private health insurance. For the target outcome of outpatient office visits, people with private insurance were less likely to visit the outpatient office than people without private insurance (mean difference = − 0.19 (95% CI − 0.29 to − 0.09)). In theory, people with private insurance should have more access to health care. However, our results indicate that there was no significant increase in the consumption of healthcare services among individuals with private health insurance. In one of the dimensions examined, those with private health insurance coverage actually used fewer of the health care available to them. One possible explanation is that the utilization of medical services was more directly correlated with the need for the service than with insurance coverage, as suggested by previous studies [40,41,42]. Private health insurance coverage does not appear to increase the utilization of health care and may ease the financial burdens on patients and social health insurance plans.

The results of subgroup analysis to identify differences between those without insurance and those with public insurance showed that most results were consistent with the total pooled results. For LOS, people with private insurance were more likely to stay longer in the hospital, compared to people with public insurance (mean difference (days) = 2.82, 95% CI 0.38–5.27). With regard to the rate of hospitalization, compared to people without any insurance, people with private insurance were more likely to be hospitalized (OR 1.67; 95% CI, 1.18–2.36). As inpatient services are more tightly linked to medical necessity than outpatient services, these results reflect the potential for private insurance to relieve patients’ financial burden.

To our best knowledge, this systematic review is the first review to assess the impact of private insurance coverage on the utilization of health care across the globe. This study strictly followed the standards for systematic reviews, including explicit eligibility criteria, duplicated independent assessments of eligibility, and a comprehensive literature search. One limitation of this study was that more than half of the included studies were conducted in the United States, which restricted the external validity of the results. Another limitation of this review is that the results may have been confounded by selection bias due to divergences in methodology among health care systems. Next, the evidence of this present study has temporal limitations. Studies on this topic were conducted prior to 2010. However, we restricted the search period to years from 2010 onward in order to focus our investigation on current insurance policy. Finally, as there is no standardized tool for the assessment of abstract quality, all abstracts included in the review were not graded in terms of quality. This fact may limit the ability of other researchers to extrapolate from the results reported here. Additional studies will be necessary to explore these issues.

Conclusion

People with private insurance did not increase their utilization of health care (outpatient services), compared to those without private insurance. Private health insurance coverage may ease the financial burdens on patients and on the public health insurance system.

Availability of data and materials

The datasets used during the current study are available from the corresponding author on reasonable request.

Abbreviations

PRISMA:

Preferred Reporting Items for Systematic Reviews and Meta-Analyses

CENTRAL:

Cochrane Central Register of Controlled Trials

ED:

Emergency department

LOS:

Length of stay

CIs:

Confidence intervals

OR:

Odds ratio

References

  1. Tamblyn R, Laprise R, Hanley JA, Abrahamowicz M, Scott S, Mayo N, et al. Adverse events associated with prescription drug cost-sharing among poor and elderly persons. Jama. 2001;285:421–9.

    Article  CAS  PubMed  Google Scholar 

  2. Manning WG, Newhouse JP, Duan N, Keeler EB, Leibowitz A, Marquis MS. Health insurance and the demand for medical care: evidence from a randomized experiment. Am Econ Rev. 1987;77:251–77.

    CAS  PubMed  Google Scholar 

  3. Fontenelle LF, Sarti TD, Camargo MBJ, Maciel ELN, Barros AJD. Utilization of the Brazilian public health system by privately insured individuals: a literature review. Cad Saude Publica. 2019;35:e00004118.

    Article  PubMed  Google Scholar 

  4. Barnett JC, Vornovitsky MS. Health insurance coverage in the United States: 2015. Washington, DC: US Government Printing Office; 2016.

    Google Scholar 

  5. Iglehart JK. Canada's health care system. In: Mass Medical Soc; 1986.

    Google Scholar 

  6. Sohn M, Jung M. Effects of public and private health insurance on medical service utilization in the National Health Insurance System: national panel study in the Republic of Korea. BMC Health Serv Res. 2016;16:503.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Bodenheimer T. Should we abolish the private health insurance industry? Int J Health Serv. 1990;20:199–220.

    Article  CAS  PubMed  Google Scholar 

  8. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Int J Surg. 2010;8:336–41.

    Article  PubMed  Google Scholar 

  9. Carrasquillo O. Health Care Utilization. In: Gellman MD, Turner JR, editors. Encyclopedia of Behavioral Medicine. New York: Springer New York; 2013. p. 909–10.

    Google Scholar 

  10. Sterne JA, Hernan MA, Reeves BC, Savovic J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. Bmj. 2016;355:i4919.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. Bmj. 2008;336:924–6.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Manager R: Version 5.0. In.: The Nordic Cochrane Centre, The Cochrane Collaboration Copenhagen, Denmark; 2008.

  13. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–88.

    Article  CAS  PubMed  Google Scholar 

  14. Abougergi MS, Avila P, Saltzman JR. Impact of insurance status and race on outcomes in Nonvariceal upper gastrointestinal hemorrhage: a nationwide analysis. J Clin Gastroenterol. 2019;53:E12–E8.

    Article  PubMed  Google Scholar 

  15. Abraham JM. How might the affordable care Act's coverage expansion provisions influence demand for medical care? Milbank Q. 2014;92:63–87.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Abraham PS, Greene M. The impact of different types of payer on healthcare resource utilization and costs among cancer patients in India. Value Health. 2017;20(5):A131.

    Google Scholar 

  17. Abraham PS, Greene M, Eguale T, Rodriguez-Monguio R, Seoane-Vazquez E. Impact of payer on healthcare resource utilization and costs among breast cancer patients in India. Value Health. 2017;20(5):A128.

    Google Scholar 

  18. Araujo MEA, Silva MT, Galvao TF, Pereira MG. Prevalence of health services usage and associated factors in the Amazon region of Brazil: A population-based cross-sectional study. BMJ Open. 2017;7(11) (no pagination).

  19. Bhandari NR, Chopra DA, Kathe N, Moore G, Lewis K, Li C, et al. Contrasting utilization of inpatient hospitalizations and emergency department visits between medicaid and commercially insured arkansans. Value Health. 2018;21(Supplement 1):S131.

    Google Scholar 

  20. Cunningham P, Sheng Y. Trends in preventable inpatient and emergency department utilization in California between 2012 and 2015. Med Care. 2018;56:544–50.

    Article  PubMed  Google Scholar 

  21. Dabbous FM, Dorey J, Thokagevistk K, Toumi M. Impact of health insurance status on health care resource utilization among diabetic patients in the United States. Value Health. 2014;17(3):A252.

    Article  Google Scholar 

  22. Fontenelle LF, Camargo MBJ, Bertoldi AD, Goncalves H, Maciel ELN, Barros AJD. Utilization of basic health units of FHS according to private health insurance. Revista de Saude Publica. 2018;52:55.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Gandhi SO, Grant LP, Sabik LM. Trends in nonemergent use of emergency departments by health insurance status. Med Care Res Rev. 2014;71:496–521.

    Article  PubMed  Google Scholar 

  24. Ginde AA, Lowe RA, Wiler JL. Health insurance status change and emergency department use among US adults. Arch Intern Med. 2012;172:642–7.

    Article  PubMed  Google Scholar 

  25. Halpern MT, Renaud JM, Vickrey BG. Impact of insurance status on access to care and out-of-pocket costs for U.S. individuals with epilepsy. Epilepsy Behav. 2011;22:483–9.

    Article  PubMed  Google Scholar 

  26. Hasegawa K, Sullivan AF, Tovar Hirashima E, Gaeta TJ, Fee C, Turner SJ, et al. A Multicenter Observational Study of US Adults with Acute Asthma: Who Are the Frequent Users of the Emergency Department? J Allergy Clin Immunol: In Pract. 2014;2:733–40.e3.

    Article  Google Scholar 

  27. Henke RM, Maeda JL, Marder WD, Friedman BS, Wong HS. Medicare and commercial inpatient resource use: impact of hospital competition. Am J Manag Care. 2013;19:e238–e48.

    PubMed  Google Scholar 

  28. Hullegie P, Klein TJ. The effect of private health insurance on medical care utilization and self-assessed health in Germany. Health Econ. 2010;19:1048–62.

    Article  PubMed  Google Scholar 

  29. Jeon B, Kwon S. Effect of private health insurance on health care utilization in a universal public insurance system: a case of South Korea. Health Policy. 2013;113:69–76.

    Article  PubMed  Google Scholar 

  30. Leach LS, Butterworth P, Whiteford H. Private health insurance, mental health and service use in Australia. Aust N Z J Psychiatry. 2012;46:468–75.

    Article  PubMed  Google Scholar 

  31. Mandsager P, Lebrun-Harris LA, Sripipatana A. Health center patients’ insurance status and healthcare use prior to implementation of the affordable care act. Am J Prev Med. 2015;49:545–52.

    Article  PubMed  Google Scholar 

  32. Pomerantz D, Machado M, DiBonaventura M. The impact of private versus public insurance on health status, work productivity and health care utilization for individuals residing in Brazil. Value Health. 2013;16(3):A76.

    Article  Google Scholar 

  33. Rice JB, Desai U, Cummings AK, Birnbaum HG, Skornicki M, Parsons NB. Burden of diabetic foot ulcers for medicare and private insurers. Diabetes Care. 2014;37:651–8.

    Article  PubMed  Google Scholar 

  34. Sarkar M, Earley ER, Asti L, Chisolm DJ. Differences in health care needs, health care utilization, and health care outcomes among children with special health care needs in Ohio: a comparative analysis between Medicaid and private insurance. J Public Health Manag Pract. 2017;23:e1–9.

    Article  PubMed  Google Scholar 

  35. Shmueli A, Savage E. Private and public patients in public hospitals in Australia. Health Policy. 2014;115:189–95.

    Article  PubMed  Google Scholar 

  36. Terveen DC, Hsu BS, Tufty GT. The impact of insurance status on hospital resource utilization in pediatric ophthalmic inpatients. J AAPOS. 2015;19(4):e65.

    Article  Google Scholar 

  37. Yoshioka Y, Tamiya N, Kashiwagi M, Sato M, Okubo I. Comparison of public and private care management agencies under public long-term care insurance in Japan: a cross-sectional study. Geriatr Gerontol Int. 2010;10:48–55.

    Article  PubMed  Google Scholar 

  38. You CH, Choi JH, Kang S, Oh EH, Kwon YD. Association between supplementary private health insurance and visits to physician offices versus hospital outpatient departments among adults with diabetes in the universal public insurance system. PLoS ONE. 2018;13(4) (no pagination).

  39. Young A, Ruble L, McGrew J. Public vs. private insurance: cost, use, accessibility, and outcomes of services for children with autism spectrum disorders. Res Autism Spectr Disord. 2009;3:1023–33.

    Article  Google Scholar 

  40. Geil P, Million A, Rotte R, Zimmermann KF. Economic incentives and hospitalization in Germany. J Appl Econ. 1997;12:295–311.

    Article  Google Scholar 

  41. Riphahn RT, Wambach A, Million A. Incentive effects in the demand for health care: a bivariate panel count data estimation. J Appl Econ. 2003;18:387–405.

    Article  Google Scholar 

  42. Jürges H. Health insurance status and physician behavior in Germany. Schmollers Jahr. 2009;129:297.

    Article  Google Scholar 

Download references

Acknowledgments

I am grateful to my department leaders and my family for their great encouragement, support and help to this project.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. Department of International Medical Servicers, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Wangfujing Dongcheng District, Beijing, 100730, China

    Congcong Zhang, Chenwei Fu, Yimin Song, Rong Feng & Yongning Li

  2. Department of Nursing, Peking Union Medical College Hospital, No.1 Shuaifuyuan, Wangfujing Dongcheng District, Beijing, 100730, China

    Xinjuan Wu

Authors
  1. Congcong Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chenwei Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yimin Song
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Rong Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Xinjuan Wu
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yongning Li
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

CZ was responsible for the search strategy, designing, testing of the data extraction form, and writing the initial draft. YL and XW provided input for the design, analyses and reporting. XW was responsible for the conception, designing of the survey and critical review the final draft. CZ and CF were involved in designing and testing of the data extraction form. CZ, CF, YS and RF contributed to quality checking of the data and the manuscript writing. All authors contributed to the protocol and approved the final manuscript.

Corresponding authors

Correspondence to Xinjuan Wu or Yongning Li.

Ethics declarations

Ethics approval and consent to participate

The present project is a systematic review based on review of publicly reported literature, which does not require ethics review.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Zhang, C., Fu, C., Song, Y. et al. Utilization of public health care by people with private health insurance: a systematic review and meta-analysis. BMC Public Health 20, 1153 (2020). https://doi.org/10.1186/s12889-020-08861-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-020-08861-9

Keywords

  • Private health insurance
  • Health care utilization
  • Systematic review
  • Meta-analysis

BMC Public Health

ISSN: 1471-2458

Contact us